News

RHS raises international profile, increases revenues and strengthens clinical expertise

Dec 16, 2016 -

Highlights

  • Revenue update
  • Flinders Fertility commence IVF and PGS cycles at new co-location facility
  • DOPlifyTM included in independent single cell WGA benchmarking study
  • RHS to present at 9th Annual Biotech Showcase – San Francisco Jan. 11th 2017
  • Tristan Hardy appointed to the RHS Clinical and Scientific Advisory Committee

Adelaide, 16th December 2016: Reproductive Health Science Limited (ASX: RHS) (“RHS” or “the Company”) is pleased to report that following the relocation of Flinders Fertility to the TechInSA Incubator alongside RHS, previously announced to the market in the RHS ASX release of 21st November, Flinders Fertility has achieved RTAC accreditation of their facility, commenced IVF services on schedule and restored RHS’ PGS service provision.  The co-location with RHS provides a unique opportunity for scientific exchange and direct clinical feedback on the RHS service provision and product suitability for IVF applications.

Click on image below to view full release

< Back to all news